Houston Methodist Baytown Hospital

Medicine & Life Sciences

1. Breast 100%
2. Carcinoma, Intraductal, Noninfiltrating 66%
3. Neoplasms 46%
4. Granulomatous Mastitis 43%
5. Breast Neoplasms 40%
6. Heart 32%
7. Heart-Assist Devices 31%
8. Transplants 26%
9. Fluorescence Microscopy 26%
10. Positron Emission Tomography Computed Tomography 25%
11. Confocal Microscopy 25%
12. Transplant Recipients 24%
13. Heart Failure 21%
14. Mammography 21%
15. Radiotherapy 20%
16. Inflammatory Breast Neoplasms 19%
17. Large-Core Needle Biopsy 19%
18. Estrogen Receptors 19%
19. Phyllodes Tumor 19%
20. Calcinosis 17%
21. Tomography 17%
22. Simulation Training 17%
23. Magnetic Resonance Imaging 17%
24. Ultrasonography 17%
25. Neoplasm Metastasis 17%
26. Biopsy 16%
27. Coronavirus 16%
28. Elasticity Imaging Techniques 16%
29. Malignant Mesothelioma 16%
30. Clinical Pathology 16%
31. RNA Interference 15%
32. Cardiotoxicity 14%
33. Recurrence 14%
34. Weaning 14%
35. Cannula 14%
36. Second Primary Neoplasms 13%
37. Blood Culture 13%
38. Knee Replacement Arthroplasties 13%
39. Radiology 13%
40. Lymph Nodes 13%
41. Pulmonary Hypertension 13%
42. Ligaments 12%
43. Reading 11%
44. Actins 11%
45. Magnetic Resonance Spectroscopy 11%
46. Lymphoma 10%
47. Adrenal Cortex Hormones 10%
48. Knee 10%
49. Disease Progression 10%
50. Prostatic Neoplasms 10%
51. Lung Neoplasms 10%
52. Adenocarcinoma 10%
53. Radiologists 10%
54. Equipment and Supplies 9%
55. Emission-Computed Tomography 9%
56. Hospitalization 9%
57. Up-Regulation 9%
58. Infections 9%
59. Joints 9%
60. Therapeutics 9%
61. Thorax 9%
62. Stroke 9%
63. Lung Diseases 8%
64. Mortality 8%
65. Fluorodeoxyglucose F18 8%
66. Education 8%
67. Small Interfering RNA 8%
68. Breast Diseases 8%
69. Survival 8%
70. Computer-Assisted Image Processing 7%
71. Nuclear Medicine 7%
72. Allografts 7%
73. Cardiovascular Diseases 7%
74. Pharmaceutical Preparations 6%
75. Radiation 6%
76. Vascular Diseases 6%
77. Diagnosis-Related Groups 6%
78. Heart Transplantation 6%
79. Positron-Emission Tomography 6%
80. Technology 6%
81. Hematologic Neoplasms 6%
82. Ovarian Neoplasms 6%
83. Immunosuppression 5%
84. Heart Ventricles 5%
85. Blood Vessels 5%
86. Triple Negative Breast Neoplasms 5%
87. Guidelines 5%
88. Datasets 5%
89. Tissue Donors 5%
90. Pleura 5%
91. Patient Readmission 5%